Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,588.70
-40.20 (-1.53%)
Aug 5, 2025, 1:30 PM IST
Nordstrom Market Cap
Mankind Pharma has a market cap or net worth of 1.09 trillion as of August 4, 2025. Its market cap has increased by 26.62% in one year.
Market Cap
1.09T
Enterprise Value
1.15T
Revenue
129.10B
Ranking
n/a
PE Ratio
56.64
Stock Price
$2,588.70
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.09T, an increase of 90.44%. That is a compound annual growth rate of 33.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 1,085.02B | -8.70% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Apollo Hospitals Enterprise | 1,057.03B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |
| Alkem Laboratories | 585.75B |